Yaroshetskiy, Andrey I. http://orcid.org/0000-0002-1484-092X
Merzhoeva, Zamira M. http://orcid.org/0000-0002-3174-5000
Tsareva, Natalia A. http://orcid.org/0000-0001-9357-4924
Trushenko, Natalia V. http://orcid.org/0000-0002-0685-4133
Nuralieva, Galia S. http://orcid.org/0000-0002-4726-4906
Konanykhin, Vasily D. http://orcid.org/0000-0002-6558-1227
Krasnoshchekova, Anna P. http://orcid.org/0000-0001-6986-1368
Avdeev, Sergey N. http://orcid.org/0000-0002-5999-2150
Article History
Received: 23 May 2022
Accepted: 21 September 2022
First Online: 1 October 2022
Declarations
:
: The study was approved by the Institutional Ethics Committee of Sechenov University (approval number: 20–20, date of approval 15/07/2020). All methods were performed in accordance with the Declaration of Helsinki and the international ethical guidelines for human biomedical research. Written informed consent was waived owing to the observational nature of the study. The waiver was approved by the Institutional Ethics Committee of Sechenov University (approval number: 20–20).
: Not applicable.
: AIY reported personal fees from GE, Philips Respironics, Covidien, Fisher & Paykel, Drager, Triton Electronics, Mindray, Pfizer, BBraun, Gilead outside the submitted work. SNA reported personal fees from Behringer Ingelheim, Pfizer, Novartis, AstraZeneca, Chiesi outside the submitted work. No other disclosers were reported.